======= SETD7 ======= == Gene Information == * **Official Symbol**: SETD7 * **Official Name**: SET domain containing 7, histone lysine methyltransferase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=80854|80854]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WTS6|Q8WTS6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SETD7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SETD7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606594|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Histone methyltransferase that specifically monomethylates 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. Plays a central role in the transcriptional activation of genes such as collagenase or insulin. Recruited by IPF1/PDX-1 to the insulin promoter, leading to activate transcription. Has also methyltransferase activity toward non-histone proteins such as p53/TP53, TAF10, and possibly TAF7 by recognizing and binding the [KR]-[STA]-K in substrate proteins. Monomethylates 'Lys-189' of TAF10, leading to increase the affinity of TAF10 for RNA polymerase II. Monomethylates 'Lys-372' of p53/TP53, stabilizing p53/TP53 and increasing p53/TP53-mediated transcriptional activation. {ECO:0000269|PubMed:12540855, ECO:0000269|PubMed:12588998, ECO:0000269|PubMed:15099517, ECO:0000269|PubMed:15525938, ECO:0000269|PubMed:16141209, ECO:0000269|PubMed:17108971}. |SET| |peptidyl-lysine monomethylation| |peptidyl-lysine dimethylation| |heterochromatin organization| |histone-lysine N-methyltransferase activity| |regulation of histone H3-K9 methylation| |protein-lysine N-methyltransferase activity| |regulation of histone methylation| |p53 binding| |histone lysine methylation| |peptidyl-lysine methylation| |histone methylation| |chromosome| |response to ethanol| |protein methylation| |protein alkylation| |regulation of histone modification| |regulation of chromatin organization| |response to alcohol| |macromolecule methylation| |response to antibiotic| |methylation| |peptidyl-lysine modification| |regulation of chromosome organization| |histone modification| |covalent chromatin modification| |chromatin binding| |response to toxic substance| |chromatin organization| |cellular response to DNA damage stimulus| |nucleolus| |peptidyl-amino acid modification| |response to drug| |chromosome organization| |regulation of organelle organization| |positive regulation of transcription, DNA-templated| |response to oxygen-containing compound| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cellular response to stress| |positive regulation of RNA metabolic process| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp210|LB-100 2μM R05 exp210]]|-2.07| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.87| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-1.79| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-1.71| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|1.71| |[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|1.79| |[[:results:exp111|R-DABN 8μM R03 exp111]]|1.86| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|1.9| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14738 * **Expression level (log2 read counts)**: 7.08 {{:chemogenomics:nalm6 dist.png?nolink |}}